Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Int J Mol Sci ; 24(15)2023 Jul 26.
Artículo en Inglés | MEDLINE | ID: mdl-37569363

RESUMEN

In this study, we investigated the potential anticancer effects of Viscum album, a parasitic plant that grows on Malus domestica (VaM) on breast cancer cells, and explored the underlying mechanisms. VaM significantly inhibited cell viability and proliferation and induced apoptosis in a dose-dependent manner. VaM also regulated cell cycle progression and effectively inhibited activation of the STAT3 signaling pathway through SHP-1. Combining VaM with low-dose doxorubicin produced a synergistic effect, highlighting its potential as a promising therapeutic. In vivo, VaM administration inhibited tumor growth and modulated key molecular markers associated with breast cancer progression. Overall, our findings provide strong evidence for the therapeutic potential of VaM in breast cancer treatment and support further studies exploring clinical applications.


Asunto(s)
Neoplasias de la Mama , Viscum album , Humanos , Femenino , Viscum album/metabolismo , Neoplasias de la Mama/metabolismo , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Apoptosis , Transducción de Señal , Proliferación Celular , Línea Celular Tumoral , Factor de Transcripción STAT3/metabolismo
2.
Pak J Pharm Sci ; 36(1): 9-16, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36967491

RESUMEN

In the current study, the protective effect of a mistletoe extract (Helixor®, HLX) on Itraconazole (ITZ)-induced hepatocellular injury and acute oxidative stress in rats was aimed to be investigated by histological, biochemical and comet assay methods. Four groups a control group, an HLX group (5mg/kg/14days/intraperitoneally (ip)), an ITZ group (100mg/kg/14days/oral) and an HLX plus ITZ group (5mg/kg/14days/ip+100mg/kg/14days/oral) were all created from 32 female Wistar albino rats. At the end of the experiment, AST and ALT liver enzymes, total oxidant status (TOS) levels and total antioxidant status (TAS) levels, histopathological analysis and comet assay were carried out. Highest genotoxicity, higher levels of plasma AST and ALT, higher TOS, more degeneration of liver histopathology including hepatocyte degeneration, hepatocyte apoptosis and necrosis, portal/periportal inflammation, bile ductus hyperplasia and multinuclear giant cell formation were observed in ITZ group (p<0.05). As opposed to that, administration of HLX plus ITZ improved histopathological changes and DNA damage and showed a dramatic decrease in AST, ALT and TOS levels (p<0.05) and an increase in TAS level (p<0.001) when compared to ITZ group. This study showed that the antioxidant properties of HLX administration significantly decreased acute oxidative stress and hepatocellular damage in rats given ITZ.


Asunto(s)
Carcinoma Hepatocelular , Neoplasias Hepáticas , Muérdago , Viscum album , Femenino , Animales , Ratas , Antioxidantes/farmacología , Antioxidantes/metabolismo , Itraconazol/farmacología , Viscum album/metabolismo , Carcinoma Hepatocelular/metabolismo , Ratas Wistar , Neoplasias Hepáticas/patología , Estrés Oxidativo , Hígado , Oxidantes/farmacología , Extractos Vegetales/farmacología , Extractos Vegetales/metabolismo
3.
Molecules ; 25(17)2020 Sep 02.
Artículo en Inglés | MEDLINE | ID: mdl-32887375

RESUMEN

Fermented aqueous extracts of Viscum album L. are widely used for cancer treatment in complementary medicine. The high molecular weight compounds viscotoxins and lectins are considered to be the main active substances in the extracts. However, a vast number of small molecules (≤1500 Da) is also expected to be present, and few studies have investigated their identities. In this study, a comprehensive metabolome analysis of samples of fermented aqueous extracts of V. album from two host tree species (Malus domestica and Pinus sylvestris), both prepared by two pharmaceutical manufacturing processes, was performed by liquid chromatography-high resolution tandem mass spectrometry (LC-HRMS/MS). A total of 212 metabolites were putatively annotated, including primary metabolites (e.g., amino acids, organic acids, etc.) and secondary metabolites (mostly phenolic compounds). A clear separation between V. album samples according to the host tree species, but not due to manufacturing processes, was observed by principal component analysis. The biomarkers responsible for this discrimination were assessed by partial least squares-discriminant analysis. Because V. album extracts from different host trees have different clinical applications, the present work highlights the possibility of characterizing the metabolome for identification and traceability of V. album fermented aqueous extracts.


Asunto(s)
Fermentación , Metaboloma , Metabolómica , Extractos Vegetales/metabolismo , Espectrometría de Masas en Tándem , Viscum album/metabolismo , Cromatografía Liquida , Análisis Discriminante , Análisis de los Mínimos Cuadrados , Análisis Multivariante , Análisis de Componente Principal
4.
J Proteomics ; 164: 52-58, 2017 07 05.
Artículo en Inglés | MEDLINE | ID: mdl-28571969

RESUMEN

Combinatorial peptide ligand libraries (CPLLs), coupled to mass spectrometry (MS) analysis, have been used to investigate in depth the proteome of Viscum album L. (VA), commonly named European mistletoe, in order to provide a first proteomic fingerprinting. For this purpose, the proteins were captured via CPLLs at two different pH values (acidic and neutral). A total of 648 non-redundant proteins were identified by using two different databases. The two pH values, chosen for bead incubations, have contributed to increment the capture ability: 56% and 31% of CPLLs species were respectively recognized at pH7.2 and at pH2.2. Finally the biological function of identified proteins was evaluated in order to understand their role on human health and the potential benefits of mistletoe extracts in medicine. SIGNIFICANCE: Viscum album L. (VA) extracts are recently used as supporting medicine for cancer therapy, improving patients' survival and increasing their quality of life in medicine. These anticancer effects are investigated and they are probably due to mistletoe's capability to favor tumor cell's death and to modulate the immune system. Although the increasing interest in VA medical benefits, the role of its components in human health remains unclear. In order to exploit this aspect, it is important to comprehensively study proteins present in Viscum album L. (VA) extracts. Nevertheless, since plant proteomics analysis is in most cases handicapped by the presence of high-abundance proteins masking the detection of the low-abundance ones, it is important to overcome this challenge. In this sense, combinatorial peptide ligand libraries (CPLLs) have been used to reduce the dynamic protein concentration range to enable the identification of a higher amount of proteins than employing conventional methods. In this work, a total of 648 non-redundant proteins were identified: 56% and 31% of CPLLs species were respectively recognized at pH7.2 and at pH2.2. This deep proteome identification was useful to investigate the biological functions of proteins in order to evaluate their potential role in human health.


Asunto(s)
Biblioteca de Péptidos , Extractos Vegetales/química , Proteínas de Plantas/química , Proteoma/química , Proteómica , Viscum album/química , Proteínas de Plantas/metabolismo , Proteoma/metabolismo , Viscum album/metabolismo
5.
Eur J Cancer ; 47(10): 1450-7, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21482461

RESUMEN

Extracts from the European mistletoe plant Viscumalbum have been studied for decades for their direct and indirect anticancer activity. Therefore, scientists were interested in identifying the active compound (mistletoe lectin) in these extracts and making it available as a highly purified molecule for drug development. Recombinant mistletoe lectin (INN: aviscumine) was produced in Escherichiacoli. It has been shown to have immunomodulatory and cytotoxic activity in invitro and in animal models and can target tumour cells. Clinical phase I studies also demonstrated immunomodulatory activity, which appears to have a positive effect on disease stabilisation. This review explores the current knowledge base for aviscumine's mechanism of action, efficacy and side-effects in both preclinical studies and clinical trials, and it considers aviscumine's potential as a cancer therapy.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Antineoplásicos/farmacología , Neoplasias/tratamiento farmacológico , Preparaciones de Plantas/farmacología , Proteínas Inactivadoras de Ribosomas Tipo 2/farmacología , Toxinas Biológicas/farmacología , Animales , Antígenos CD/metabolismo , Línea Celular Tumoral , Ensayos Clínicos como Asunto , Ensayos de Selección de Medicamentos Antitumorales/métodos , Escherichia coli/metabolismo , Humanos , Factores Inmunológicos , Inmunoterapia/métodos , Ratones , Neoplasias/metabolismo , Extractos Vegetales/farmacología , Conformación Proteica , Ratas , Proteínas Recombinantes/química , Sialiltransferasas/metabolismo , Viscum album/metabolismo
6.
Planta Med ; 74(2): 163-7, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18203060

RESUMEN

Extracts of Viscum album L. produced by a specific homogenization procedure contain viscotoxins (VT) and liposome-like membrane vesicles, formed from cellular membranes. Interactions between these membrane structures and viscotoxins are characterized in this work. Binding properties of viscotoxins with mistletoe extracts or isolated membrane vesicles were analyzed by gel permeation chromatography (GPC) and centrifugation, followed by HPLC/UV for viscotoxin detection. The experiments show that a part of the viscotoxins is bound to membrane vesicles, and that this binding to the membrane structures is reversible. In the case of the vesicles studied from an extract of 100 mg plant material per mL (0.30 mM phospholipids, 244 microg/mL VT), 64 microg/mL VTs are bound to the membranes. The binding properties of the viscotoxin isoforms are different. VTA3 clearly binds more intensively to membrane structures than VTA2 or VTA1. Possible interaction of viscotoxins with DNA, which is also discussed as a mechanism of viscotoxin action, could be shown to be negligible in the framework of these experiments.


Asunto(s)
Membrana Celular/metabolismo , Proteínas de Plantas/metabolismo , Proteínas Inactivadoras de Ribosomas/metabolismo , Viscum album/metabolismo , Cinética , Extractos Vegetales/metabolismo , Plantas Medicinales , Tioninas/metabolismo
7.
Anticancer Res ; 25(1B): 601-10, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15816634

RESUMEN

With the techniques of vital microscopic and reflection spectrometric imaging, representative characteristics of microcirculation and immunology of white blood cells were evaluated before, during and after radiotherapy and chemotherapy of patients suffering from ear, nose and throat carcinomas. Adverse effects of radiotherapy and chemotherapy on the microcirculation and the immune system were decreased and reconstitution processes were accelerated by complementary administration of a standardized mistletoe extract (Iscador).


Asunto(s)
Carcinoma/tratamiento farmacológico , Carcinoma/radioterapia , Microcirculación/efectos de los fármacos , Neoplasias de Oído, Nariz y Garganta/tratamiento farmacológico , Neoplasias de Oído, Nariz y Garganta/radioterapia , Extractos Vegetales/uso terapéutico , Proteínas de Plantas/uso terapéutico , Anciano , Movimiento Celular , Hematócrito , Humanos , Neoplasias Laríngeas/tratamiento farmacológico , Neoplasias Laríngeas/radioterapia , Leucocitos/inmunología , Masculino , Persona de Mediana Edad , Neoplasias Faríngeas/tratamiento farmacológico , Neoplasias Faríngeas/radioterapia , Factores de Tiempo , Viscum album/metabolismo
8.
Acta Crystallogr D Biol Crystallogr ; 60(Pt 12 Pt 2): 2295-304, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15583377

RESUMEN

This is the first report of the structural studies of a novel ribosome-inactivating protein (RIP) obtained from the Himalayan mistletoe (Viscum album) (HmRip). HmRip is a type II heterodimeric protein consisting of a toxic enzyme (A-chain) with an active site for ribosome inactivation and a lectin subunit (B-chain) with well defined sugar-binding sites. The crystal structure of HmRip has been determined at 3.8 A resolution and refined to a crystallographic R factor of 0.228 (R(free) = 0.271). A comparison of this structure with other type II RIPs reveals the presence of distinct structural features in the active site of the A-chain and in the 2gamma sugar-binding site of the B-chain. The conformation of the side chain of Tyr110, which is a conserved active-site residue in the A subunit, is strikingly different from those observed in other mistletoe RIPs, indicating its unique substrate-binding preference. The deletion of two important residues from the kink region after Ala231 in the 2gamma subdomain of the B-chain results in a significantly different conformation of the sugar-binding pocket. A ribosome-recognition site has also been identified in HmRip. The site is a shallow cavity, with the conserved residues Arg51, Asp70, Thr72 and Asn73 involved in the binding. The conformations of the antigenic epitopes of residues 1-20, 85-103 and 206-223 differ from those observed in other type II RIPs, resulting in the distinct antigenicity and pharmacological properties of HmRip.


Asunto(s)
Preparaciones de Plantas/química , Proteínas de Plantas/química , Ribosomas/química , Toxinas Biológicas/química , Secuencia de Aminoácidos , Antígenos , Sitios de Unión , Carbohidratos/química , Cristalografía por Rayos X , ADN Complementario/metabolismo , Dimerización , Electrones , Epítopos/química , Glicosilación , Modelos Moleculares , Datos de Secuencia Molecular , Unión Proteica , Conformación Proteica , Pliegue de Proteína , Estructura Secundaria de Proteína , Proteínas Inactivadoras de Ribosomas Tipo 2 , Homología de Secuencia de Aminoácido , Especificidad por Sustrato , Viscum album/metabolismo
9.
J Ethnopharmacol ; 88(1): 99-106, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12902058

RESUMEN

Immunostimulant effects of the dietary intake of various medicinal plant extracts on fish, rainbow trout (Oncorhynchus mykiss), were investigated. For this purpose fish were fed with diets containing aqueous extracts of mistletoe (Viscum album), nettle (Urtica dioica), and ginger (Zingiber officinale). Food containing lyophilized extracts of these plants as 0.1 and 1% was used at a rate of 2% of body weight per day for three weeks. At the end of the experimental period, various parameters of non-specific defence mechanisms, including extracellular and intracellular respiratory burst activities, phagocytosis in blood leukocytes and total plasma protein level were examined. Specific growth rates (SGRs) and condition factors (CFs) of the fish were also measured. Plant materials tested for immunostimulatory food additives caused an enhanced extracellular respiratory burst activity (P<0.001) compared to the control group. Especially the rainbow trout fed with a diet containing 1% aqueous extract of powdered ginger roots for three weeks exhibited a significant non-specific immune response. Phagocytosis and extracellular burst activity of blood leukocytes were significantly higher in this group than those in the control group. All plant extracts added to fish diet increased the total protein level in plasma except 0.1% ginger. The highest level of plasma proteins was observed in the group fed with 1% ginger extract containing feed.


Asunto(s)
Adyuvantes Inmunológicos/fisiología , Oncorhynchus mykiss/inmunología , Plantas Medicinales/inmunología , Animales , Formación de Anticuerpos/efectos de los fármacos , Proteínas Sanguíneas/química , Proteínas Sanguíneas/efectos de los fármacos , Ingestión de Alimentos , Enfermedades de los Peces/tratamiento farmacológico , Enfermedades de los Peces/prevención & control , Alimentos , Zingiber officinale/inmunología , Zingiber officinale/metabolismo , Crecimiento/efectos de los fármacos , Crecimiento/fisiología , Inmunidad Celular/efectos de los fármacos , Leucocitos/efectos de los fármacos , Leucocitos/metabolismo , Muérdago/inmunología , Muérdago/metabolismo , Oncorhynchus mykiss/metabolismo , Fagocitos/efectos de los fármacos , Fagocitos/metabolismo , Fagocitosis , Hojas de la Planta/inmunología , Hojas de la Planta/metabolismo , Estallido Respiratorio/efectos de los fármacos , Estallido Respiratorio/fisiología , Superóxidos/metabolismo , Turquía , Viscum album/inmunología , Viscum album/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA